SS Innovations International, Inc. SSII
Rating
Rating Factors
Company Overview
SS Innovations International, Inc. (SSII) is a medical technology company focused on the development, manufacturing, and commercialization of robotic surgical systems and related digital healthcare technologies. The company operates primarily in the robotic-assisted surgery and healthcare technology industries, with an emphasis on improving surgical accessibility and reducing procedural costs in emerging and developed healthcare markets. Its flagship platform, the SSI Mantra surgical robotic system, is designed to support minimally invasive procedures across multiple specialties, including cardiac surgery, general surgery, gynecology, thoracic surgery, and urology.
The company’s primary revenue drivers are expected to include sales and leasing of robotic surgical systems, recurring instrument and consumable sales, service agreements, and training-related activities. SS Innovations positions itself as a lower-cost alternative to incumbent robotic surgery platforms, particularly targeting hospitals and healthcare systems in cost-sensitive regions. The company was founded by cardiac surgeon Dr. Sudhir Srivastava, who has been associated with robotic and minimally invasive surgical innovation for decades. SSII evolved from earlier robotic surgery development efforts into a publicly traded entity focused on expanding adoption of domestically developed surgical robotics technology, particularly in India and other international markets.
Income Statement
Balance Sheet
Cash Flow
Filings
Price History
- Low
- $3.11
- Current
- $3.26
- High
- $10.00
Valuation
Dividends and Shares
Corporate Info
3rd Floor
Udyog Vihar, Phase 3
Gurugram, 122016